|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenues | |||
| Cost of revenues (exclusive of depreciation and amortization) | |||
| Total revenue | |||
| Operating expenses: | |||
| Cost of revenue | |||
| Sales and marketing | |||
| Research and development | |||
| General and administrative | |||
| Depreciation and amortization | |||
| Impairment expense | |||
| Net loss (gain) on digital assets | |||
| Loss on disposition of Janover Pro | |||
| (Gain) from changes in fair value of contingent consideration | |||
| Total operating expenses | |||
| Operating (loss) income | |||
| Change in fair value of future equity obligations | |||
| Change in fair value of marketable securities | |||
| Interest income | |||
| Other income | |||
| Total other income (expense) | |||
| Interest expense | |||
| (Loss) gain from derivative instruments | |||
| Investment and other (expense) income, net | |||
| (Loss) income before income taxes | |||
| Income tax (expense) benefit | |||
| Net (loss) income | |||
| Net (loss) income per share: | |||
| Basic (in dollars per share) | |||
| Diluted (in dollars per share) | |||
| Weighted-average shares outstanding: | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
